ABCLAbCellera Biologics, Inc.

11.32USDMkt Cap: 3.67B $P/E:

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Pha…

Key Statistics

Company
Market Cap3.67B $
Enterprise Value3.07B $
Revenue (TTM)66.17M $
Gross Profit-131.60M $
Net Income (TTM)-146.41M $
Revenue/Share0.2190 USD
Last Price11.32 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees562
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINCA00288U1066
Valuation
P/E (Trailing)
P/E (Forward)-15.83
PEG
EV/EBITDA-15.34
EV/Revenue46.34
P/S55.44
P/B3.87
EPS (TTM)-0.54
EPS (Forward)-0.71
52W Range
11.1427% of range11.80
52W High11.80 USD
52W Low11.14 USD
Profitability
Gross Margin-198.88%
Oper. Margin-1550.05%
EBITDA Margin0.00%
Profit Margin-194.88%
ROE-15.14%
ROA-10.79%
Growth
Revenue Growth-76.30%
Earnings Growth
Cash Flow & Leverage
Operating CF-131.29M $
CapEx (TTM)42.77M $
FCF Margin-70.17%
FCF Yield-1.27%
Net Debt-404.49M $
Net Debt/EBITDA2.02
Balance Sheet
Debt/Equity0.15
Current Ratio12.77
Quick Ratio11.23
Book Value/Sh2.924 USD
Cash/Share1.762 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)17.13 USD
Upside (mean)+51.3%
Target Range9.000 USD30.00 USD
$9.000+51.3% to mean$30.00
# Analysts8
Ownership
Shares Out.324.05M
Float209.09M
Insiders21.74%
Institutions36.68%
Short Interest
Short Ratio8.3d
Short % Float20.41%
Short % Out.15.77%
Shares Short48.32M
Short (prev mo.)48.56M
Technical
SMA 507.209 (+57.0%)
SMA 2004.760 (+137.8%)
Beta1.19
S&P 52W Chg19.18%
Avg Vol (30d)4.54M
Avg Vol (10d)14.94M
Technical Indicators
RSI (14)73.9
MACD1.4682
MACD Signal1.1132
MACD Hist.+0.3550
BB Upper13.73 USD
BB Middle8.383 USD
BB Lower3.035 USD
BB Width127.60%
ATR (14)0.8122 USD
Vol Ratio (20d)0.44x